WO2017140116A1 - 无创血糖浓度检测辅助装置 - Google Patents

无创血糖浓度检测辅助装置 Download PDF

Info

Publication number
WO2017140116A1
WO2017140116A1 PCT/CN2016/103044 CN2016103044W WO2017140116A1 WO 2017140116 A1 WO2017140116 A1 WO 2017140116A1 CN 2016103044 W CN2016103044 W CN 2016103044W WO 2017140116 A1 WO2017140116 A1 WO 2017140116A1
Authority
WO
WIPO (PCT)
Prior art keywords
receiving
transmitting
control line
blood glucose
glucose concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2016/103044
Other languages
English (en)
French (fr)
Inventor
张贯京
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Qianhai AnyCheck Information Technology Co Ltd
Original Assignee
Shenzhen Qianhai AnyCheck Information Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Qianhai AnyCheck Information Technology Co Ltd filed Critical Shenzhen Qianhai AnyCheck Information Technology Co Ltd
Publication of WO2017140116A1 publication Critical patent/WO2017140116A1/zh
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/35—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light
    • G01N21/3577—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using infrared light for analysing liquids, e.g. polluted water
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose

Definitions

  • the present invention relates to the technical field of life health, and in particular, to a non-invasive blood glucose concentration detecting auxiliary device.
  • Diabetes is a group of metabolic diseases characterized by hyperglycemia.
  • Hyperglycemia is caused by defects in insulin secretion or its biological effects, or both.
  • Hyperglycemia which is persistent in people with diabetes, causes chronic damage and dysfunction in various tissues, especially the eyes, kidneys, heart, blood vessels, and nerves.
  • a more effective way to control the treatment of diabetes is to strictly control the blood glucose concentration by frequently detecting blood sugar levels and injecting insulin, thereby suppressing complications caused by diabetes and alleviating the suffering of diabetic patients. Therefore, it is very important to regularly check the blood glucose level of patients.
  • a primary object of the present invention is to provide a non-invasive blood glucose concentration detecting auxiliary device, which aims to solve the problem of user's monitoring of blood sugar in a non-invasive state.
  • the present invention provides a non-invasive blood glucose concentration detecting auxiliary device comprising a control line, a transmitting portion, a spring, a rotating shaft, a receiving portion and a controller, wherein:
  • the control line includes a transmission control line and a reception control line;
  • the transmitting portion includes a transmitting clip, a launching clip cover and a transmitting triode, and the transmitting clip cover covers the transmitting clip;
  • the receiving portion includes a receiving clip, a receiving clip cover and a receiving transistor, and the receiving clip cover covers the receiving clip;
  • the launching clip and the receiving clip are connected by the rotating shaft;
  • the spring is disposed between the launching clamp and the receiving clamp;
  • the controller sends a signal through the emission control line to control the emission of the infrared light emitted by the emission transistor in the muscle tissue of the user, and the infrared light transmitted from the blood of the muscle tissue according to the receiving transistor
  • the ratio of the infrared light emitted by the emission transistor calculates the absorption rate of the blood of the muscle tissue, and the blood sugar content in the blood of the muscle tissue of the user is obtained according to the absorbance of the blood of the muscle tissue.
  • the transmitting portion further includes an emitting PCB board disposed between the transmitting clip and the launching clip cover.
  • the emission PCB is provided with the emission transistor, and the emission transistor is vertically disposed on the emission PCB.
  • one end of the emission control line is connected to the emission PCB, and the other end of the emission control line is connected to the controller.
  • the receiving portion further comprises a receiving PCB board, and the receiving PCB board is disposed between the receiving clip seat and the receiving clip cover.
  • the receiving transistor is disposed on the receiving PCB.
  • one end of the receiving control line is connected to the receiving PCB, and the other end of the receiving control line is connected to the controller.
  • the emitting portion further includes a rubber sleeve, and the rubber sleeve is disposed on the launching clip cover.
  • the shape of the spring is a U-shaped constriction.
  • the non-invasive blood glucose concentration detecting auxiliary device of the invention has a simple structure and is convenient to use.
  • the device can clamp the muscle or tissue of the user through the spring, the launching clamp and the receiving clamp, and is convenient to use.
  • the controller processes the blood glucose, and finally obtains the blood sugar level in the blood of the user's muscle or tissue, and assists in determining the current blood sugar level of the user.
  • FIG. 1 is a schematic plan view showing a preferred embodiment of the non-invasive blood glucose concentration detecting auxiliary device of the present invention
  • FIG. 2 is a side view showing the structure of a casing of the non-invasive blood glucose concentration detecting auxiliary device of the present invention.
  • FIG. 1 is a schematic plan view showing a preferred embodiment of the non-invasive blood glucose concentration detecting assisting device of the present invention
  • FIG. 2 is a schematic side view showing the housing of the non-invasive blood glucose concentration detecting assisting device of the present invention.
  • the non-invasive blood glucose concentration detecting auxiliary device includes a control line, a transmitting portion, and a spring 4
  • the control line includes a transmission control line 1 and a reception control line 13;
  • the transmitting portion includes a transmitting clip 2, a launching clip cover 3 and a transmitting triode 8, and the transmitting clip cover 3 is covered on the launching clip 2;
  • the receiving portion includes a receiving clip 11, a receiving clip cover 12 and a receiving transistor 9, and the receiving clip cover 12 is covered on the receiving clip 11;
  • the launching clamp 2 and the receiving clamp 11 are connected by the rotating shaft 5, [0033] the spring 4 is disposed between the launching clamp 2 and the receiving clamp 11;
  • the controller 14 sends a signal through the emission control line 1 to control the emission transistor 8 to emit infrared light to illuminate the muscle tissue blood of the user, and transmits the blood from the muscle tissue according to the receiving transistor 9.
  • the ratio of the infrared light to the infrared light emitted from the emitter transistor 8 calculates the absorption rate of the blood of the muscle tissue, and the blood sugar level in the blood tissue of the user is obtained according to the absorbance of the blood of the muscle tissue.
  • the non-invasive blood glucose concentration detecting auxiliary device includes a control line, a transmitting portion, a spring 4, a rotating shaft 5, a receiving portion, and a controller 14. It should be noted that the numbers of the control line, the transmitting portion and the receiving portion are not shown in Fig. 1.
  • the control line includes a transmission control line 1 and a reception control line 13.
  • the transmitting portion comprises three parts, namely a transmitting clip holder 2, a launching clip cover 3 and a transmitting triode 8.
  • the emitting clip cover 3 covers the transmitting clip holder 2 to form a cavity, and the transmitting PCB board 7 is fixed at the emission.
  • the emission control line 1 passes through the cavity between the emitter holder 2 and the emitter cover 3 to the emission PCB board 7, and the emission PCB board 7 is provided with a transmitting transistor 8.
  • the transmitting transistor 8 is vertically disposed on the transmitting PCB board 7.
  • the receiving portion also includes three parts, a receiving holder 11, a receiving cover 12 and a receiving transistor 9.
  • the receiving clip cover 12 covers the receiving holder 11 to form a cavity, and the receiving control line 13 passes through the receiving holder 11 and receives the cavity formed by the clip cover 12 to the receiving PCB 10.
  • a receiving PCB board 10 is fixed in the cavity, and a receiving transistor 9 is disposed on the receiving PCB board 10.
  • the transmitting transistor 8 and the receiving transistor 9 may be disposed opposite to each other or may be disposed on the same horizontal plane.
  • the launching clamp 2 and the receiving clamp 11 are connected by the rotating shaft 5, and the spring 4 is disposed between the transmitting clamp 2 and the receiving clamp 11, and the number of the springs 4 may be two.
  • the spring 4 can be arranged in a U-shaped neck shape to improve the stability of the non-invasive blood sugar concentration detecting auxiliary device.
  • the two springs 4 are respectively caught in the slots of the lower portion of the transmitting holder 2 and the receiving holder 11, which are not shown in the drawings.
  • the upper end of the transmitting holder 2 and the receiving holder 11 can clamp the muscle or tissue of the user under the action of the spring 4, the tissue It can be the position of the tiger's mouth in the hand, or it can be the earlobe.
  • One end of the emission control line 1 is connected to the transmitting PCB board 7, and the other end of the transmitting control line 1 is connected to the controller 14 for transmitting an electrical signal sent by the controller 14.
  • One end of the receiving control line 13 is connected to the receiving PCB board, and the other end of the receiving control line 13 is connected to the controller 14 for converting the received infrared light through the photoelectric signal to obtain electricity. The signal is then sent to the controller 14 via the receive control line 13.
  • the controller 14 transmits a signal to the transmitting transistor of the transmitting portion through the emission control line 1 to cause the transmitting transistor 8 to emit a specific Infrared light, the wavelength of the infrared light is set in the infrared wavelength range, and the specific infrared light can pass through the muscle or tissue of the user.
  • the absorption transistor 8 is absorbed.
  • the controller 14 sends a signal through the emission control line 1 to control the emission transistor 8 to emit infrared light to illuminate the muscle tissue blood of the user, and according to the receiving transistor 9, blood from the muscle tissue.
  • the ratio of the transmitted infrared light to the infrared light emitted from the emitter transistor 8 calculates the absorption rate of the muscle tissue blood.
  • the controller 14 obtains the blood sugar level in the blood of the muscle tissue of the user based on the absorbance of the muscle tissue blood to achieve an effect of assisting in determining the current blood sugar level of the user.
  • the rubber cover 6 is further disposed on the emitting portion, the rubber sleeve 6 is disposed on the launching cover 3, and the external infrared light is blocked by the rubber sleeve 6 after use, thereby reducing The effect of infrared light on the error in the final determination of blood glucose levels.
  • the rubber sleeve 6 is made of soft rubber, which improves the comfort of the user.
  • the top of the rubber sleeve 6 is provided with a mouthpiece which is sized to match the firing holder 2, so that the use of sputum does not affect the measurement of blood sugar of the muscle or tissue.
  • the non-invasive blood glucose concentration detecting auxiliary device of the invention can clamp the muscle or tissue of the user through the spring, the launching clamp and the receiving clamping seat, and is convenient for the user to operate; the external infrared light is blocked by the rubber sleeve, and the operation is reduced. Due to the influence of infrared light on the final measurement of blood sugar content; through the controller and the emission control line, the transmitting transistor emits specific infrared light, which can pass through the user's muscles or tissues, and part of the infrared light is absorbed by the user's muscles.
  • tissue blood glucose absorption part of the infrared light is sent to the receiving triode
  • the receiving transistor is converted by the photoelectric signal, and the obtained electric signal is transmitted to the controller through the receiving control line, and the controller processes the electric blood signal to finally obtain the blood sugar content in the blood of the user's muscle or tissue, and assists in judging the current user's current Blood sugar levels.
  • the non-invasive blood glucose concentration detecting auxiliary device of the invention has a simple structure and is convenient to use.
  • the device can clamp the muscle or tissue of the user through the spring, the launching clamp and the receiving clamp to facilitate the user's operation; the external infrared light is blocked by the rubber sleeve, and the final blood sugar content is determined by infrared light.
  • the transmitting transistor emits specific infrared light, which can pass through the muscle or tissue of the user, and part of the infrared light is absorbed by the blood sugar of the user's muscle or tissue, and part of the infrared

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

一种无创血糖浓度检测辅助装置，包括控制线、发射部、弹簧（4）、转轴（5）、接收部和控制器（14）。控制线包括发射控制线（1）和接收控制线（13）；发射部包括发射夹座（2）、发射夹盖（3）和发射三极管（8），接收部包括接收夹座（11）、接收夹盖（12）和接收三极管（9）；发射夹座（2）与接收夹座（11）通过转轴（5）相连接；通过弹簧（4）、发射夹座（2）与接收夹座（11）夹紧使用者的肌肉或组织，方便使用者的操作。该辅助装置辅助判断使用者当前的血糖水平。

Description

发明名称：无创血糖浓度检测辅助装置
技术领域
[0001] 本发明涉及生命健康的技术领域， 尤其涉及一种无创血糖浓度检测辅助装置。
背景技术
[0002] 糖尿病是一组以高血糖为特征的代谢性疾病。 高血糖则是由于胰岛素分泌缺陷 或其生物作用受损， 或两者兼有引起。 患有糖尿病吋长期存在的高血糖， 导致 各种组织， 特别是眼、 肾、 心脏、 血管、 神经的慢性损害、 功能障碍。 目前而 言， 较为有效的控制治疗糖尿病的方法是通过频繁的检测血糖值和注射胰岛素 来对血糖浓度进行严格地控制， 从而抑制由糖尿病导致的并发症， 减轻糖尿病 患者的痛苦。 因此， 定期对患者进行血糖值检测意义非常重大。
[0003] 目前检测血糖的方法分为有创、 微创和无创的方法。 有创和微创的检测方法均 具有不同程度的组织入侵性， 而血糖的检测是一段吋间内的连续测量， 这对患 者来说带来了较大的痛苦， 并且有感染的危险， 而且检测费用较高， 所以局限 性较大。
[0004] 因此， 有必要设计一种无创血糖浓度检测辅助装置， 通过光电信号实现对无创 血糖的监测， 且无创伤， 从而减轻使用者的痛苦， 又可以随吋监测血糖变化， 改善使用者的身体健康。
技术问题
[0005] 本发明的主要目的在于提供一种无创血糖浓度检测辅助装置， 旨在解决使用者 的在无创状态下对血糖的监测的问题。
问题的解决方案
技术解决方案
[0006] 为实现上述目的， 本发明提供了一种无创血糖浓度检测辅助装置， 所述无创血 糖浓度检测辅助装置包括控制线、 发射部、 弹簧、 转轴、 接收部和控制器， 其 中：
[0007] 所述控制线包括发射控制线和接收控制线； [0008] 所述发射部包括发射夹座、 发射夹盖和发射三极管， 所述发射夹盖覆盖在所述 发射夹座上；
[0009] 所述接收部包括接收夹座、 接收夹盖和接收三极管， 所述接收夹盖覆盖在所述 接收夹座上；
[0010] 所述发射夹座与接收夹座通过所述转轴相连接；
[0011] 所述弹簧设置在所述发射夹座和接收夹座之间；
[0012] 所述控制器通过所述发射控制线发送信号来控制所述发射三极管发射红外光照 射在使用者的肌肉组织血液， 根据所述接收三极管从所述肌肉组织血液透射出 的红外光与所述发射三极管发射出的红外光的比例计算出所述肌肉组织血液的 吸收率， 以及根据所述肌肉组织血液的吸光度得到使用者的肌肉组织的血液中 的血糖含量。
[0013] 优选地， 所述发射部还包括发射 PCB板， 该发射 PCB板设置在所述发射夹座与 发射夹盖之间。
[0014] 优选地， 所述发射 PCB板上设置有所述发射三极管， 所述发射三极管垂直设置 于所述发射 PCB板上。
[0015] 优选地， 所述发射控制线的一端与所述发射 PCB板相连接， 所述发射控制线的 另外一端与所述控制器相连接。
[0016] 优选地， 所述接收部还包括接收 PCB板， 该接收 PCB板设置在所述接收夹座与 接收夹盖之间。
[0017] 优选地， 所述接收三极管设置在所述接收 PCB板上。
[0018] 优选地， 所述接收控制线的一端与所述接收 PCB板相连接， 所述接收控制线的 另外一端与所述控制器相连接。
[0019] 优选地， 所述发射部还包括胶套， 该胶套设置在所述发射夹盖上。
[0020] 优选地， 所述弹簧的形状为 U型缩口。
发明的有益效果
有益效果
[0021] 相较于现有技术， 本发明无创血糖浓度检测辅助装置结构简单且方便使用。 该 装置通过弹簧、 发射夹座与接收夹座能够夹紧使用者的肌肉或组织， 方便使用 者的操作； 通过胶套， 外部的红外光被遮挡， 减少了因红外光对最终的血糖含 量测定的误差影响； 通过控制器和发射控制线， 使发射三极管发射出特定的红 外光， 能够透过使用者的肌肉或组织， 一部分的红外光被使用者的肌肉或组织 的血糖吸收， 一部分的红外光发送到接收三极管， 接收三极管通过光电信号转 化， 将得到的电信号通过接收控制线传输到控制器， 控制器通过电信号处理， 最终得到使用者的肌肉或组织的血液中的血糖含量， 辅助判断使用者当前的血 糖水平。
对附图的简要说明
附图说明
[0022] 图 1是本发明无创血糖浓度检测辅助装置优选实施例的平面结构示意图；
[0023] 图 2是本发明无创血糖浓度检测辅助装置的壳体的侧面结构示意图。
[0024]
[0025] 本发明目的的实现、 功能特点及优点将结合实施例， 参照附图做进一步说明。
本发明的实施方式
[0026] 应当理解， 此处所描述的具体实施例仅仅用以解释本发明， 并不用于限定本发 明。
[0027] 参照图 1和图 2所示， 图 1是本发明无创血糖浓度检测辅助装置优选实施例的平 面结构示意图； 图 2是本发明无创血糖浓度检测辅助装置的壳体的侧面结构示意 图。
[0028] 在本实施例中， 所述无创血糖浓度检测辅助装置包括控制线、 发射部、 弹簧 4
、 转轴 5、 接收部和控制器 14， 其中：
[0029] 所述控制线包括发射控制线 1和接收控制线 13;
[0030] 所述发射部包括发射夹座 2、 发射夹盖 3和发射三极管 8， 所述发射夹盖 3覆盖在 所述发射夹座 2上；
[0031] 所述接收部包括接收夹座 11、 接收夹盖 12和接收三极管 9， 所述接收夹盖 12覆 盖在所述接收夹座 11上；
[0032] 所述发射夹座 2与接收夹座 11通过所述转轴 5相连接， [0033] 所述弹簧 4设置在所述发射夹座 2和接收夹座 11之间；
[0034] 所述控制器 14通过所述发射控制线 1发送信号来控制所述发射三极管 8发射红外 光照射在使用者的肌肉组织血液， 根据所述接收三极管 9从所述肌肉组织血液透 射出的红外光与所述发射三极管 8发射出的红外光的比例计算出所述肌肉组织血 液的吸收率， 以及根据所述肌肉组织血液的吸光度得到使用者的肌肉组织的血 液中的血糖含量。
[0035] 在本实施例中， 所述无创血糖浓度检测辅助装置， 包括控制线、 发射部、 弹簧 4、 转轴 5、 接收部和控制器 14。 需要说明的是， 控制线、 发射部和接收部的标 号在图 1中未示出。
[0036] 所述控制线包括发射控制线 1和接收控制线 13。 所述发射部包括三个部分， 分 别是发射夹座 2、 发射夹盖 3和发射三极管 8， 发射夹盖 3覆盖在发射夹座 2上而形 成空腔， 发射 PCB板 7固定在所述发射夹座 2与发射夹盖 3之间的空腔上， 发射控 制线 1穿过发射夹座 2与发射夹盖 3之间的空腔至发射 PCB板 7， 发射 PCB板 7上设 置有发射三极管 8， 发射三极管 8垂直设置于发射 PCB板 7上。
[0037] 所述接收部也同样包括三个部分， 分别是接收夹座 11、 接收夹盖 12和接收三极 管 9。 接收夹盖 12覆盖在接收夹座 11上而形成空腔， 接收控制线 13穿过接收夹座 11、 接收夹盖 12形成的空腔至接收 PCB板 10。 空腔内固定有接收 PCB板 10， 接收 PCB板 10上设置有接收三极管 9。 所述发射三极管 8与接收三极管 9可以彼此正对 向设置， 也可以设置在同一水平面上。
[0038] 所述发射夹座 2与接收夹座 11通过所述转轴 5相连接， 所述弹簧 4设置在所述发 射夹座 2和接收夹座 11之间， 弹簧 4的数量可以是两个， 弹簧 4可设置成 U型缩口 状， 提高了该无创血糖浓度检测辅助装置的稳定性。 两个弹簧 4分别卡在发射夹 座 2与接收夹座 11的下部的槽内， 该槽在图中未示出。 当使用者在使用该无创血 糖浓度检测辅助装置对血糖浓度进行无创检测吋， 在弹簧 4的作用下， 发射夹座 2与接收夹座 11的上端可夹紧使用者的肌肉或组织， 该组织可以是手部虎口的位 置， 也可以是耳垂处。
[0039] 所述发射控制线 1的一端与所述发射 PCB板 7相连接， 所述发射控制线 1的另外 一端与所述控制器 14相连接， 用于将控制器 14发送的电信号发送至所述发射部 。 所述接收控制线 13的一端与所述接收 PCB板相连接， 所述接收控制线 13的另外 一端与所述控制器 14相连接， 用于将接收到的红外光通过光电信号转化， 获得 电信号， 再通过接收控制线 13将获得电信号发送到控制器 14。 具体地， 当发射 夹座 2与接收夹座 11的上端可夹紧使用者的肌肉或组织后， 控制器 14通过发射控 制线 1向发射部的发射三极管发射信号， 使发射三极管 8发射出特定的红外光， 该红外光的波长设定在红外波长区间内， 该特定的红外光能够透过使用者的肌 肉或组织。 在本实施例中， 由于一部分的红外光被使用者的肌肉或组织的血糖 吸收， 另一部分透出的红外光发送到接收三极管 9， 当肌肉或组织的血糖浓度较 高吋， 吸收发射三极管 8发射的红外光能力就越强， 因此， 接收三极管 9将接收 到的红外光强度就低； 当肌肉或组织的血糖浓度较低吋， 与发射三极管 8发射的 红外光的能力就越弱， 因此， 接收三极管 9将接收到的红外光强度就高。 在本实 施例， 所述控制器 14通过所述发射控制线 1发送信号来控制所述发射三极管 8发 射红外光照射在使用者的肌肉组织血液， 根据所述接收三极管 9从所述肌肉组织 血液透射出的红外光与所述发射三极管 8发射出的红外光的比例计算出所述肌肉 组织血液的吸收率。 所述控制器 14根据所述肌肉组织血液的吸光度得到使用者 的肌肉组织的血液中的血糖含量， 以达到辅助判断使用者当前的血糖水平的效 果。
[0040] 在本实施例中， 由于发射部上还设置有胶套 6， 该胶套 6设置在所述发射夹盖 3 上， 在使用吋， 外部的红外光被胶套 6遮挡， 减少了因红外光对最终的血糖含量 测定的误差影响。 胶套 6的材质为软橡胶， 提高了使用者在使用吋的舒适度。 此 夕卜， 胶套 6的顶端设置有一幵口， 该幵口的大小与发射夹座 2相匹配， 因此在使 用吋， 不会对肌肉或组织的血糖的测定造成影响。
[0041]
[0042] 本发明无创血糖浓度检测辅助装置通过弹簧、 发射夹座与接收夹座能够夹紧使 用者的肌肉或组织， 方便使用者的操作； 通过胶套， 外部的红外光被遮挡， 减 少了因红外光对最终的血糖含量测定的误差影响； 通过控制器和发射控制线， 使发射三极管发射出特定的红外光， 能够透过使用者的肌肉或组织， 一部分的 红外光被使用者的肌肉或组织的血糖吸收， 一部分的红外光发送到接收三极管 ， 接收三极管通过光电信号转化， 将得到的电信号通过接收控制线传输到控制 器， 控制器通过电信号处理， 最终得到使用者的肌肉或组织的血液中的血糖含 量， 辅助判断使用者当前的血糖水平。
[0043]
[0044] 以上仅为本发明的优选实施例， 并非因此限制本发明的专利范围， 凡是利用本 发明说明书及附图内容所作的等效结构或等效功能变换， 或直接或间接运用在 其他相关的技术领域， 均同理包括在本发明的专利保护范围内。
工业实用性
[0045] 相较于现有技术， 本发明无创血糖浓度检测辅助装置结构简单且方便使用。 该 装置通过弹簧、 发射夹座与接收夹座能够夹紧使用者的肌肉或组织， 方便使用 者的操作； 通过胶套， 外部的红外光被遮挡， 减少了因红外光对最终的血糖含 量测定的误差影响； 通过控制器和发射控制线， 使发射三极管发射出特定的红 外光， 能够透过使用者的肌肉或组织， 一部分的红外光被使用者的肌肉或组织 的血糖吸收， 一部分的红外光发送到接收三极管， 接收三极管通过光电信号转 化， 将得到的电信号通过接收控制线传输到控制器， 控制器通过电信号处理， 最终得到使用者的肌肉或组织的血液中的血糖含量， 辅助判断使用者当前的血 糖水平。 =。

Claims

权利要求书
[权利要求 1] 一种无创血糖浓度检测辅助装置， 其特征在于， 所述无创血糖浓度检 测辅助装置包括控制线、 发射部、 弹簧、 转轴、 接收部和控制器， 其 中： 所述控制线包括发射控制线和接收控制线； 所述发射部包括发射 夹座、 发射夹盖和发射三极管， 所述发射夹盖覆盖在所述发射夹座上 ； 所述接收部包括接收夹座、 接收夹盖和接收三极管， 所述接收夹盖 覆盖在所述接收夹座上， 所述发射夹座与接收夹座通过所述转轴相连 接； 所述弹簧设置在所述发射夹座和接收夹座之间； 所述控制器通过 所述发射控制线发送信号来控制所述发射三极管发射红外光照射在使 用者的肌肉组织血液， 根据所述接收三极管从所述肌肉组织血液透射 出的红外光与所述发射三极管发射出的红外光的比例计算出所述肌肉 组织血液的吸收率， 以及根据所述肌肉组织血液的吸光度得到使用者 的肌肉组织的血液中的血糖含量。
[权利要求 2] 如权利要求 1所述的无创血糖浓度检测辅助装置， 其特征在于， 所述 发射部还包括发射 PCB板， 该发射 PCB板设置在所述发射夹座与发射 夹盖之间。
[权利要求 3] 如权利要求 2所述的无创血糖浓度检测辅助装置， 其特征在于， 所述 发射 PCB板上设置有所述发射三极管， 所述发射三极管垂直设置于所 述发射 PCB板上。
[权利要求 4] 如权利要求 3所述的无创血糖浓度检测辅助装置， 其特征在于， 所述 发射控制线的一端与所述发射 PCB板相连接， 所述发射控制线的另外 一端与所述控制器相连接。
[权利要求 5] 如权利要求 1所述的无创血糖浓度检测辅助装置， 其特征在于， 所述 接收部还包括接收 PCB板， 该接收 PCB板设置在所述接收夹座与接收 夹盖之间。
[权利要求 6] 如权利要求 5所述的无创血糖浓度检测辅助装置， 其特征在于， 所述 接收三极管设置在所述接收 PCB板上。
[权利要求 7] 如权利要求 6所述的无创血糖浓度检测辅助装置， 其特征在于， 所述 接收控制线的一端与所述接收 PCB板相连接， 所述接收控制线的另外 一端与所述控制器相连接。
[权利要求 8] 如权利要求 6所述的无创血糖浓度检测辅助装置， 其特征在于， 所述 接收控制线的一端与所述接收 PCB板相连接， 所述接收控制线的另外 一端与所述控制器相连接。
[权利要求 9] 如权利要求 1~7任一项所述的无创血糖浓度检测辅助装置， 其特征在 于， 所述弹簧的形状为 U型缩口。
PCT/CN2016/103044 2016-02-20 2016-10-24 无创血糖浓度检测辅助装置 Ceased WO2017140116A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610096056.0 2016-02-20
CN201610096056.0A CN105548065A (zh) 2016-02-20 2016-02-20 无创血糖浓度检测辅助装置

Publications (1)

Publication Number Publication Date
WO2017140116A1 true WO2017140116A1 (zh) 2017-08-24

Family

ID=55827406

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2016/103044 Ceased WO2017140116A1 (zh) 2016-02-20 2016-10-24 无创血糖浓度检测辅助装置

Country Status (2)

Country Link
CN (1) CN105548065A (zh)
WO (1) WO2017140116A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105548065A (zh) * 2016-02-20 2016-05-04 深圳市前海安测信息技术有限公司 无创血糖浓度检测辅助装置
CN205433707U (zh) * 2016-02-20 2016-08-10 深圳市圣必智科技开发有限公司 用于无创血糖浓度检测的辅助夹子
CN205683086U (zh) * 2016-04-21 2016-11-16 深圳市前海康启源科技有限公司 手持式无创血糖检测装置

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5313940A (en) * 1991-05-15 1994-05-24 Nihon Kohden Corporation Photo-electric pulse wave measuring probe
CN1366177A (zh) * 2000-12-28 2002-08-28 株式会社拜奥克斯 血糖分光光度测定仪及其测定方法
CN204336925U (zh) * 2014-12-06 2015-05-20 深圳市易特科信息技术有限公司 可穿戴式无创血糖测量设备
CN204542107U (zh) * 2015-03-04 2015-08-12 邓伟廷 适合于手指采样的无创多指标传感器
CN105548065A (zh) * 2016-02-20 2016-05-04 深圳市前海安测信息技术有限公司 无创血糖浓度检测辅助装置
CN205433707U (zh) * 2016-02-20 2016-08-10 深圳市圣必智科技开发有限公司 用于无创血糖浓度检测的辅助夹子

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5313940A (en) * 1991-05-15 1994-05-24 Nihon Kohden Corporation Photo-electric pulse wave measuring probe
CN1366177A (zh) * 2000-12-28 2002-08-28 株式会社拜奥克斯 血糖分光光度测定仪及其测定方法
CN204336925U (zh) * 2014-12-06 2015-05-20 深圳市易特科信息技术有限公司 可穿戴式无创血糖测量设备
CN204542107U (zh) * 2015-03-04 2015-08-12 邓伟廷 适合于手指采样的无创多指标传感器
CN105548065A (zh) * 2016-02-20 2016-05-04 深圳市前海安测信息技术有限公司 无创血糖浓度检测辅助装置
CN205433707U (zh) * 2016-02-20 2016-08-10 深圳市圣必智科技开发有限公司 用于无创血糖浓度检测的辅助夹子

Also Published As

Publication number Publication date
CN105548065A (zh) 2016-05-04

Similar Documents

Publication Publication Date Title
WO2009085818A3 (en) Optical sensor and method for detecting a patient condition
CN101496718B (zh) 颈动脉脉搏波检测传感器调整装置
US20160081603A1 (en) Reflection-Type Multi-Sensor Array Blood Oxygen Detection Device
CN107019823A (zh) 一种智能仿生心率同步负压养生保健仪
CN105548065A (zh) 无创血糖浓度检测辅助装置
CN203970511U (zh) 一种具有感应功能的中药内科用刺络针
CN205433707U (zh) 用于无创血糖浓度检测的辅助夹子
CN107343791B (zh) 无创血糖检测装置
KR102293154B1 (ko) 생체신호측정장치
WO2012149841A1 (zh) 睡眠窒息检测治疗仪
CN209186716U (zh) 一种无创血糖检测仪
CN204683612U (zh) 一种与自行车握把相适配的血氧监测指套
CN202364268U (zh) 具血流检测功能的翻盖手机
CN215384008U (zh) 一种内科用脉动血氧计
US20130102863A1 (en) Non-Invasive Trans-Reflective Monitoring Apparatus
CN209899400U (zh) 一种无创血糖仪用耳夹
CN204971302U (zh) 糖尿病检测治疗仪
CN202761925U (zh) 带心率和血氧饱和度检测的激光血氧治疗仪
CN208892596U (zh) 低频脉冲老年人理疗探测机
CN107049285A (zh) 具有设备连接结构的脉搏血氧传感器
CN206687713U (zh) 一种糖尿病检测治疗仪
CN215017364U (zh) 一种可辅助探查肌肉深度、便于调节按摩力度的仪器
CN207870885U (zh) 具有设备连接结构的脉搏血氧传感器
CN202277616U (zh) 穴位针灸器
CN205031271U (zh) 社区智能健康体检的血氧测量系统

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16890343

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205 DATED 23.01.2019)

122 Ep: pct application non-entry in european phase

Ref document number: 16890343

Country of ref document: EP

Kind code of ref document: A1